PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
2,948,981
Share change
+49,823
Total reported value
$59,254,000
Price per share
$20.05
Number of holders
53
Value change
+$145,273
Number of buys
29
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q1 2017

As of 31 Mar 2017, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,948,981 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Tieton Capital Management, LLC, Moors & Cabot, Inc., Uniplan Investment Counsel, Inc., VANGUARD GROUP INC, CRAWFORD INVESTMENT COUNSEL INC, BLAIR WILLIAM & CO/IL, Granite Investment Partners, LLC, DIMENSIONAL FUND ADVISORS LP, and RBF Capital, LLC. This page lists 53 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.